Immune booster shows promise against deadly fungus

NCT ID NCT04979052

Ongoing Disease control Sponsor: Radboud University Medical Center Source: ClinicalTrials.gov ↗

First seen May 13, 2026 · Last updated May 19, 2026 · Updated 1 time

Summary

This study tests whether adding a drug called interferon-gamma to standard antifungal therapy helps adults with candidemia, a severe fungal blood infection, clear the infection faster. About 200 participants will receive either standard care alone or standard care plus the study drug. The main goal is to see how quickly the fungus disappears from the blood.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CANDIDEMIA are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Show contact details

Locations

Centre Hospitalier Universitaire Vaudois

Lausanne, 1005, Switzerland
Duke University

Durham, North Carolina, 27708, United States
Hellenic Institute for the Study of Sepsis (HISS)

Athens, 11528, Greece
Klinikum Der Johann Wolfgang Von Goethe Universitaet

Frankfurt am Main, 60590, Germany
Radboudumc

Nijmegen, Gelderland, 6525 GA, Netherlands
Universitatea de Medicina si Farmacie luliu Hatieganu

Cluj-Napoca, 400348, Romania

Conditions

Explore the condition pages connected to this study.

CANDIDEMIA